Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma (English)
- New search for: van de Schans, S. A.
- New search for: Wymenga, A. N.
- New search for: van Spronsen, D. J.
- New search for: Schouten, H. C.
- New search for: Coebergh, J. W.
- New search for: Janssen-Heijnen, M. L.
- New search for: van de Schans, S. A.
- New search for: Wymenga, A. N.
- New search for: van Spronsen, D. J.
- New search for: Schouten, H. C.
- New search for: Coebergh, J. W.
- New search for: Janssen-Heijnen, M. L.
In:
ANNALS OF ONCOLOGY
;
23
, 5
;
1280-1286
;
2012
-
ISSN:
- Article (Journal) / Print
-
Title:Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma
-
Contributors:van de Schans, S. A. ( author ) / Wymenga, A. N. ( author ) / van Spronsen, D. J. ( author ) / Schouten, H. C. ( author ) / Coebergh, J. W. ( author ) / Janssen-Heijnen, M. L. ( author )
-
Published in:ANNALS OF ONCOLOGY ; 23, 5 ; 1280-1286
-
Publisher:
- New search for: OXFORD UNIVERSITY PRESS
-
Publication date:2012-01-01
-
Size:7 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.992
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.992 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 23, Issue 5
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1083
-
DNA ploidy in endometrial cancer: unfinished business?Terada, K. et al. | 2012
- 1085
-
Recent developments in treatments targeting castration-resistant prostate cancer bone metastasesLoriot, Y. / Massard, C. / Fizazi, K. et al. | 2012
- 1095
-
Esophageal carcinoma advances in treatment results for locally advanced disease: reviewHerskovic, A. / Russell, W. / Liptay, M. / Fidler, M. J. / Al-Sarraf, M. et al. | 2012
- 1104
-
Preferences for cancer treatments: an overview of methods and applications in oncologyBlinman, P. / King, M. / Norman, R. / Viney, R. / Stockler, M. R. et al. | 2012
- 1111
-
Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of expertsReck, M. / Barlesi, F. / Crino, L. / Henschke, C. I. / Isla, D. / Stiebeler, S. / Spigel, D. R. et al. | 2012
- 1121
-
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 studyVici, P. / Brandi, M. / Giotta, F. / Foggi, P. / Schittulli, F. / Di Lauro, L. / Gebbia, N. / Massidda, B. / Filippelli, G. / Giannarelli, D. et al. | 2012
- 1130
-
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysisCortes, J. / Calvo, V. / Ramirez-Merino, N. / OShaughnessy, J. / Brufsky, A. / Robert, N. / Vidal, M. / Munoz, E. / Perez, J. / Dawood, S. et al. | 2012
- 1138
-
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trialEjlertsen, B. / Aldridge, J. / Nielsen, K. V. / Regan, M. M. / Henriksen, K. L. / Lykkesfeldt, A. E. / Muller, S. / Gelber, R. D. / Price, K. N. / Rasmussen, B. B. et al. | 2012
- 1144
-
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapyGiordano, A. / Giuliano, M. / De Laurentiis, M. / Arpino, G. / Jackson, S. / Handy, B. C. / Ueno, N. T. / Andreopoulou, E. / Alvarez, R. H. / Valero, V. et al. | 2012
- 1151
-
High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapyBouvard, B. / Hoppe, E. / Soulie, P. / Georgin-Mege, M. / Jadaud, E. / Abadie-Lacourtoisie, S. / Petit Le Manac'h, A. / Laffitte, A. / Levasseur, R. / Audran, M. et al. | 2012
- 1156
-
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancerRojo, F. / Garcia-Parra, J. / Zazo, S. / Tusquets, I. / Ferrer-Lozano, J. / Menendez, S. / Eroles, P. / Chamizo, C. / Servitja, S. / Ramirez-Merino, N. et al. | 2012
- 1164
-
A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancerPallis, A. G. / Boukovinas, I. / Ardavanis, A. / Varthalitis, I. / Malamos, N. / Georgoulias, V. / Mavroudis, D. et al. | 2012
- 1170
-
Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients `on behalf of the Group of Surgeons from the French Unicancer Federation'Classe, J. M. / Baffert, S. / Sigal-Zafrani, B. / Fall, M. / Rousseau, C. / Alran, S. / Rouanet, P. / Belichard, C. / Mignotte, H. / Ferron, G. et al. | 2012
- 1178
-
Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometriumPradhan, M. / Abeler, V. M. / Danielsen, H. E. / Sandstad, B. / Trope, C. G. / Kristensen, G. B. / Risberg, B. A. et al. | 2012
- 1185
-
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trialGladieff, L. / Ferrero, A. / De Rauglaudre, G. / Brown, C. / Vasey, P. / Reinthaller, A. / Pujade-Lauraine, E. / Reed, N. / Lorusso, D. / Siena, S. et al. | 2012
- 1190
-
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacyTwelves, C. / Scheithauer, W. / McKendrick, J. / Seitz, J. F. / Van Hazel, G. / Wong, A. / Diaz-Rubio, E. / Gilberg, F. / Cassidy, J. et al. | 2012
- 1198
-
Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancerHuh, J. W. / Jeong, Y. Y. / Kim, H. R. / Kim, Y. J. et al. | 2012
- 1207
-
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patientsCrea, F. / Fornaro, L. / Paolicchi, E. / Masi, G. / Frumento, P. / Loupakis, F. / Salvatore, L. / Cremolini, C. / Schirripa, M. / Graziano, F. et al. | 2012
- 1214
-
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trialLohr, J. M. / Haas, S. L. / Bechstein, W. O. / Bodoky, G. / Cwiertka, K. / Fischbach, W. / Folsch, U. R. / Jager, D. / Osinsky, D. / Prausova, J. et al. | 2012
- 1223
-
Third CECOG consensus on the systemic treatment of non-small-cell lung cancerBrodowicz, T. / Ciuleanu, T. / Crawford, J. / Filipits, M. / Fischer, J. R. / Georgoulias, V. / Gridelli, C. / Hirsch, F. R. / Jassem, J. / Kosmidis, P. et al. | 2012
- 1229
-
The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trialsClarey, J. / Kao, S. C. / Clarke, S. J. / Vardy, J. et al. | 2012
- 1234
-
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancerMichaelson, M. D. / Bellmunt, J. / Hudes, G. R. / Goel, S. / Lee, R. J. / Kantoff, P. W. / Stein, C. A. / Lardelli, P. / Pardos, I. / Kahatt, C. et al. | 2012
- 1241
-
Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapyde Bono, J. S. / Molife, L. R. / Sonpavde, G. / Maroto, J. P. / Calvo, E. / Cartwright, T. H. / Loesch, D. M. / Feit, K. / Das, A. / Zang, E. A. et al. | 2012
- 1250
-
Optimal prostate-specific antigen screening interval for prostate cancerKobayashi, D. / Takahashi, O. / Fukui, T. / Glasziou, P. P. et al. | 2012
- 1254
-
Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosisFossa, A. / Fiskvik, I. H. / Kolstad, A. / Lauritzsen, G. F. / Aurlien, E. / Blystad, A. K. / Hole, K. H. / Ikonomou, I. M. / Holte, H. et al. | 2012
- 1259
-
Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapyCampbell, B. A. / Hornby, C. / Cunninghame, J. / Burns, M. / MacManus, M. / Ryan, G. / Lau, E. / Seymour, J. F. / Wirth, A. et al. | 2012
- 1267
-
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study GroupSchmitz, N. / Zeynalova, S. / Glass, B. / Kaiser, U. / Cavallin-Stahl, E. / Wolf, M. / Haenel, M. / Loeffler, M. / Truemper, L. / Pfreundschuh, M. et al. | 2012
- 1274
-
Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphomaAlvarez, R. / Dupuis, J. / Plonquet, A. / Christov, C. / Copie-Bergman, C. / Hemery, F. / Gaillard, I. / El Gnaoui, T. / Kuhnowski, F. / Bedoui, M. et al. | 2012
- 1280
-
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphomavan de Schans, S. A. / Wymenga, A. N. / van Spronsen, D. J. / Schouten, H. C. / Coebergh, J. W. / Janssen-Heijnen, M. L. et al. | 2012
- 1287
-
A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinomaMa, B. B. / Kam, M. K. / Leung, S. F. / Hui, E. P. / King, A. D. / Chan, S. L. / Mo, F. / Loong, H. / Yu, B. K. / Ahuja, A. et al. | 2012
- 1293
-
Multidisciplinary team working across different tumour types: analysis of a national surveyLamb, B. W. / Sevdalis, N. / Taylor, C. / Vincent, C. / Green, J. S. et al. | 2012
- 1301
-
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safetyGomez-Roca, C. A. / Lacroix, L. / Massard, C. / De Baere, T. / Deschamps, F. / Pramod, R. / Bahleda, R. / Deutsch, E. / Bourgier, C. / Angevin, E. et al. | 2012
- 1307
-
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignanciesArkenau, H. T. / Plummer, R. / Molife, L. R. / Olmos, D. / Yap, T. A. / Squires, M. / Lewis, S. / Lock, V. / Yule, M. / Lyons, J. et al. | 2012
- 1314
-
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanomaStebbing, J. / Dalgleish, A. / Gifford-Moore, A. / Martin, A. / Gleeson, C. / Wilson, G. / Brunet, L. R. / Grange, J. / Mudan, S. et al. | 2012
- 1320
-
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC projectGonzalez, C. A. / Megraud, F. / Buissonniere, A. / Lujan Barroso, L. / Agudo, A. / Duell, E. J. / Boutron-Ruault, M. C. / Clavel-Chapelon, F. / Palli, D. / Krogh, V. et al. | 2012
- 1325
-
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deathsNeppl-Huber, C. / Zappa, M. / Coebergh, J. W. / Rapiti, E. / Rachtan, J. / Holleczek, B. / Rosso, S. / Aareleid, T. / Brenner, H. / Gondos, A. et al. | 2012
- 1335
-
A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patientsDumont, A. G. / Rink, L. / Godwin, A. K. / Miettinen, M. / Joensuu, H. / Strosberg, J. R. / Gronchi, A. / Corless, C. L. / Goldstein, D. / Rubin, B. P. et al. | 2012
- 1341
-
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesSaad, F. / Brown, J. E. / Van Poznak, C. / Ibrahim, T. / Stemmer, S. M. / Stopeck, A. T. / Diel, I. J. / Takahashi, S. / Shore, N. / Henry, D. H. et al. | 2012
- 1348
-
Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trialZhang, R. X. / Wu, X. J. / Wan, D. S. / Lu, Z. H. / Kong, L. H. / Pan, Z. Z. / Chen, G. et al. | 2012
- 1353
-
Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled studyEnblom, A. / Johnsson, A. / Hammar, M. / Onelov, E. / Steineck, G. / Borjeson, S. et al. | 2012
- 1362
-
Attributable causes of cancer in Japan in 2005-systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in JapanInoue, M. / Sawada, N. / Matsuda, T. / Iwasaki, M. / Sasazuki, S. / Shimazu, T. / Shibuya, K. / Tsugane, S. et al. | 2012
- 1370
-
EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzleFornaro, L. / Crea, F. / Masi, G. / Paolicchi, E. / Loupakis, F. / Graziano, F. / Salvatore, L. / Ronzoni, M. / Ricci, V. / Cremolini, C. et al. | 2012
- 1371
-
HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?Iorfida, M. / Dellapasqua, S. / Bagnardi, V. / Cardillo, A. / Rotmensz, N. / Mastropasqua, M. G. / Bottiglieri, L. / Goldhirsch, A. / Viale, G. / Colleoni, M. et al. | 2012
- iv5
-
Oral presentationsBonnetain, F. / Dousseau, A. / Bert, B. / Bengt, G. / Haustermans, K. / Conroy, T. / Van Laethem, J. L. / Labianca, R. / Macarulla, T. / Tabernero, J. et al. | 2012
- iv19
-
Poster discussionsHeras, P. / Niarou, V. / Andrikopoulos, E. / Spiliopoulou, A. / Braimakis, A. et al. | 2012
- iv31
-
PostersKraja, B. / Pupuleku, F. / Harizi, I. / Kullolli, S. / Mone, I. / Babameto, A. / Prifti, S. et al. | 2012
- iv119
-
Author index| 2012
- v6
-
LecturesDoroshow, J. et al. | 2012
- v12
-
DiagnosticsEinert, T. R. / Schmidt, G. / Binnig, G. et al. | 2012
- v23
-
TherapeuticsAzimi, A. et al. | 2012
- v33
-
Technology & tools developmentPefani, E. / Panoskaltsis, N. / Mantalaris, A. / Georgiadis, M. C. / Pistikopoulos, E. N. et al. | 2012
- v38
-
Computational / bioinformaticsPeach, H. F. / Johnson, P. W. / Johnson, S. / Jones, L. K. / Jones, M. / Sharpe, R. / Shaw, E. / Turtiainen, T. / Tuff, A. et al. | 2012